The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction
- PMID: 12646615
- DOI: 10.4049/jimmunol.170.7.3534
The B cell coreceptor CD22 associates with AP50, a clathrin-coated pit adapter protein, via tyrosine-dependent interaction
Abstract
The B cell coreceptor CD22 plays an important role in regulating signal transduction via the B cell Ag receptor. Studies have shown that surface expression of CD22 can be modulated in response to binding of ligand (i.e., mAb). Thus, it is possible that alterations in the level of CD22 expression following binding of natural ligand(s) may affect its ability to modulate the Ag receptor signaling threshold at specific points during B cell development and differentiation. Therefore, it is important to delineate the physiologic mechanism by which CD22 expression is controlled. In the current study, yeast two-hybrid analysis was used to demonstrate that CD22 interacts with AP50, the medium chain subunit of the AP-2 complex, via tyrosine-based internalization motifs in its cytoplasmic domain. This interaction was further characterized using yeast two-hybrid analysis revealing that Tyr(843) and surrounding amino acids in the cytoplasmic tail of CD22 comprise the primary binding site for AP50. Subsequent studies using transfectant Jurkat cell lines expressing wild-type or mutant forms of CD22 demonstrated that either Tyr(843) or Tyr(863) is sufficient for mAb-mediated internalization of CD22 and that these motifs are involved in its interaction with the AP-2 complex, as determined by coprecipitation of alpha-adaptin. Finally, experiments were performed demonstrating that treatment of B cells with either intact anti-Ig Ab or F(ab')(2) blocks ligand-mediated internalization of CD22. In conclusion, these studies demonstrate that internalization of CD22 is dependent on its association with the AP-2 complex via tyrosine-based internalization motifs.
Similar articles
-
Cell surface sialic acids do not affect primary CD22 interactions with CD45 and surface IgM nor the rate of constitutive CD22 endocytosis.Glycobiology. 2004 Nov;14(11):939-49. doi: 10.1093/glycob/cwh126. Epub 2004 Jul 7. Glycobiology. 2004. PMID: 15240561
-
Cognate B cell signaling via MHC class II: differential regulation of B cell antigen receptor and MHC class II/Ig-alpha beta signaling by CD22.J Immunol. 2004 Jan 1;172(1):195-201. doi: 10.4049/jimmunol.172.1.195. J Immunol. 2004. PMID: 14688326
-
CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation.J Exp Med. 1996 Feb 1;183(2):547-60. doi: 10.1084/jem.183.2.547. J Exp Med. 1996. PMID: 8627166 Free PMC article.
-
CD22, a B lymphocyte-specific adhesion molecule that regulates antigen receptor signaling.Annu Rev Immunol. 1997;15:481-504. doi: 10.1146/annurev.immunol.15.1.481. Annu Rev Immunol. 1997. PMID: 9143697 Review.
-
The B cell antigen receptor complex: mechanisms and implications of tyrosine kinase activation.Immunol Res. 1994;13(4):299-310. doi: 10.1007/BF02935621. Immunol Res. 1994. PMID: 7542303 Review.
Cited by
-
Impact of Endocytosis Mechanisms for the Receptors Targeted by the Currently Approved Antibody-Drug Conjugates (ADCs)-A Necessity for Future ADC Research and Development.Pharmaceuticals (Basel). 2021 Jul 15;14(7):674. doi: 10.3390/ph14070674. Pharmaceuticals (Basel). 2021. PMID: 34358100 Free PMC article. Review.
-
CD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemia.Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16852-7. doi: 10.1073/pnas.1007896107. Epub 2010 Sep 14. Proc Natl Acad Sci U S A. 2010. PMID: 20841423 Free PMC article.
-
Human CD22 Inhibits Murine B Cell Receptor Activation in a Human CD22 Transgenic Mouse Model.J Immunol. 2017 Nov 1;199(9):3116-3128. doi: 10.4049/jimmunol.1700898. Epub 2017 Sep 29. J Immunol. 2017. PMID: 28972089 Free PMC article.
-
Siglecs as targets for therapy in immune-cell-mediated disease.Trends Pharmacol Sci. 2009 May;30(5):240-8. doi: 10.1016/j.tips.2009.02.005. Epub 2009 Apr 7. Trends Pharmacol Sci. 2009. PMID: 19359050 Free PMC article. Review.
-
Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact.Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6104-9. doi: 10.1073/pnas.0400851101. Epub 2004 Apr 12. Proc Natl Acad Sci U S A. 2004. PMID: 15079087 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials